Could FDA-approved Alzheimer drug reduce risk of future memory problems? Get paid to check

Florida is partaking in a global clinical trial to test whether Lecanemab, the first drug fully approved to treat early Alzheimer’s, can benefit people at risk of developing the disease … Click to Continue »